p53 expression in dedifferentiated chondrosarcoma

Wesley W. Simms, Nelson G. Ordóñez, Dennis Johnston, Alberto G. Ayala, Bogdan Czerniak

Research output: Contribution to journalArticlepeer-review

49 Scopus citations


Background. p53 acts as a tumor suppressor gene because of to its negative control of the cell cycle and its central role in programmed cell death. It frequently is mutated, as observed in a variety of human neoplasms. The mutations inhibit tumor-suppressor activities of p53, which may gain a new function of tumor promotion. In this study, p53 was investigated in various components of dedifferentiated chondrosarcoma and correlated with their proliferative activities. Methods. Immunohistochemical assays for p53, Ki- 67, and proliferating cell nuclear antigen (PCNA) were used in a series of eight dedifferentiated chondrosarcomas of bone. The cartilaginous component was low grade (Grade I-II) in five cases. It was predominantly low grade with foci of a high grade (Grade III) chondrosarcoma in the remaining three cases. The noncartilaginous (dedifferentiated) high grade component consisted of malignant fibrous histiocytoma in five cases and osteosarcoma in three. Results. Regardless of the histological type, diffuse strong nuclear staining for p53 occurred in the high grade noncartilaginous component of all eight of the tumors. The low grade cartilaginous component of six cases was negative for p53, with focal weak staining in the two remaining cases. The high grade cartilaginous component showed strong positive staining for this protein in all three cases. Ki-67 and PCNA expression were similar to that of p53. Conclusions. The percentage of p53 positive staining roughly was parallel to the proliferating fraction of cells in various components of dedifferentiated chondrosarcoma. Moreover, p53 overexpression was consistently present in the high grade noncartilaginous (dedifferentiated) component of the tumor and was accompanied by increased proliferative activity.

Original languageEnglish (US)
Pages (from-to)223-227
Number of pages5
Issue number2
StatePublished - Jul 15 1995


  • dedifferentiated chondrosarcoma
  • Ki-67
  • p53
  • PCNA expression

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'p53 expression in dedifferentiated chondrosarcoma'. Together they form a unique fingerprint.

Cite this